PA-452

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NamePA-452

Drug Alias NameRXR antagonists (University of Tokyo)retinoid X receptor agonist (University of Tokyo)retinoid X receptor agonist (Tokyo University)PA-451PA-452

ClassificationSmall molecules

Mechanisms of ActionInsulin sensitizersRetinoid X receptor inhibitors

TargetsRetinoid X receptor

Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Tokyo

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Tokyo

Active IndicationsN/A

Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A